Fisetin alleviates pulmonary arterial hypertension by inhibiting the TGF-β1/Smad 2/3 signaling pathway
Saudi Pharmaceutical Journal · 2026-06 · 34 (3)
DOI: 10.1007/s44446-026-00092-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, online erschienen am 25.06.2026. Verfasst von Yanhong Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, No.215 Heping Xi Road, Xinhua District, Shijia…. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hebei Provincial Department of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, No.215 Heping Xi Road, Xinhua District, Shijiazhuang, 050000, Hebei, China.
- Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, No.215 Heping Xi Road, Xinhua District, Shijiazhuang, 050000, Hebei, China. 26200003@hebmu.edu.cn.
Förderung
- Hebei Provincial Department of Science and Technology
Zitieren
APA
Xu, Y., Kang, S., Gong, X., & Yuan, Y. (2026). Fisetin alleviates pulmonary arterial hypertension by inhibiting the TGF-β1/Smad 2/3 signaling pathway. Saudi Pharmaceutical Journal, 34(3). https://doi.org/10.1007/s44446-026-00092-0
Vancouver
Xu Y, Kang S, Gong X, Yuan Y. Fisetin alleviates pulmonary arterial hypertension by inhibiting the TGF-β1/Smad 2/3 signaling pathway. Saudi Pharmaceutical Journal. 2026;34(3). doi:10.1007/s44446-026-00092-0
BibTeX
@article{Xu2026,
author = {Xu, Yanhong and Kang, Shiwei and Gong, Xiaowei and Yuan, Yadong},
title = {Fisetin alleviates pulmonary arterial hypertension by inhibiting the TGF-β1/Smad 2/3 signaling pathway},
journal = {Saudi Pharmaceutical Journal},
year = {2026},
volume = {34},
number = {3},
doi = {10.1007/s44446-026-00092-0}
}
EUVIMED